memo - Magazine of European Medical Oncology

The first year of Memo – Reporting oncological progress in Europe

Wolfgang Hilbe

Current status of immunotherapy for cancer treatment

D. Wolf

Radioimmunotherapy – still experimental? Rational, proven indications and future trends

G. Hess

Immunotherapy of colorectal cancer

D. Nagorsen, D. Rüttinger

Alemtuzumab in chronic lymphocytic leukaemia, other lymphoproliferative disease and autoimmune disorders

M. Fiegl, G. Gastl, G. Hopfinger, K. Eigenberger, A. Zabernigg, T. Schenk, F. Falkner, A. Falkner, S. Sodia, M. Doubek, Y. Brychtova, A. Panovska, R. Greil, J. Mayer

Current status of peptide vaccines for cancer immunotherapy in malignant myeloid diseases

J. Greiner, M. Schmitt

Treatment of metastatic breast cancer: a historical perspective

C. C. Zielinski

Gene expression analyses in acute myeloid leukaemia (AML): current status and perspectives

U. Bacher, A. Kohlmann, C. Haferlach, W. Kern, S. Schnittger, T. Haferlach

Small cell lung cancer

F. Ploner

Non-small cell lung cancer

M. Dediu, W. Hilbe

Colorectal cancer

W. Eisterer

Pancreatic cancer

G. Pall

Gastric cancer

E. Wöll

Breast cancer

S. Braun, A. Zabernigg, A. G. Zeimet

Latest progress in treatment of gynaecological cancers

A. G. Zeimet, D. Reimer, C. Marth

"Not only presidential candidates from Illinois" Haematology news from ASCO 2008

W. Willenbacher

The detection of circulating tumour cells in blood of metastatic breast cancer patients is of prognostic relevance

O. Zach, B. Zellhofer, M. Födermayr, H. Kasparu, M. Girschikofsky, W. Hehenwarter, H. Hauser, R. Függer, W. Havlicek, D. Lutz

Academic clinical trials in the 21st century – where do we go from here? The research approach of the Arbeitsgemeinschaft Medikamentöse Tumortherapie (AGMT)

V. Kurtev, R. Greil

Announcement